Current Report No. 02/2017

Information on the grant from the NCRD

Current Report No. 02/2017

The Board of Directors of NESTMEDIC SA, a joint-stock company, with its registered office in Wrocław (the “Company”) announces that on June 13, 2017, the Company received information from the National Center for Research and Development with a positive reply to the application of the Company concerning its involvement in the Smart Growth Operational Programme 2014-2020, measure 1.1/activity 1.1.1 and getting qualified to receive co-funding for the “PREGNABIT, a New Generation Telemedical System for Monitoring Fetal Well-being” the total nett value of the project: PLN 6,933,643.98; co-financing value: PLN 4,960,115.88; project delivery: 2016-2020.

The co-funding for the above mentioned project is the highest the Company has ever been awarded. The aim of the project research is further development of the first generation of PREGNABIT along with its teleIT platform, developing, certification and introduction of the second generation of the PREGNABIT device, with new technological solutions and functionalities, relevant for both clinicians and patients. The second generation of PRENGNABIT means further development of the already applied solutions and introduction of new ones in the world-class, innovative first generation PREGNABIT device for wireless monitoring of the fetal well-being by means of cardiotocography (CTG) technology used in the mobile device sending test results to the Telemonitoring Medical Center by means of a wireless telecommunications networks. Part of the project, we are planning to conduct comprehensive R&D works aimed at developing a product innovation on a global scale, the second generation of the PREGNABIT telemedical system. The project includes three stages: conceptual development works, then industrial ones, whose results are to be assessed at the last stage of clinical trials. Delivering on the project will enrich the company offer with a new generation device which will outperform the competition in many respects, most importantly in terms of reliability, accuracy and user-friendliness.

The project has been evaluated positively under the “Fast Track” Measure 1.1 of the Smart Growth Operational Programme 2014-2020 and will be co-financed from the European Fund of Regional Development and the state budget. The terms and conditions of financing will not be different from the commonly applied ones for these types of projects. The information meets the significant information criterion because the total value it pertains to exceeds 10% of the Company’s equity.

Legal basis: § 3 (1)(7) of Exhibit 3 to the Alternative “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”